- UAA Congress 2025

Back

Final Presentation Format

Moderated Poster Abstract

Eposter Presentation

Eposter in PDF Format

https://storage.unitedwebnetwork.com/files/1237/b979dbfc6c64471153c93c285ba93380.pdf

Accept format: PDF. The file size should not be more than 5MB

Eposter in Image Format

https://storage.unitedwebnetwork.com/files/1237/1dbf407b083367f25ba276884c6c1628.jpg

Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB

Abstract

Abstract Title

The Comparison of Maintenance and Induction Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer

Presentation Type

Moderated Poster Abstract

Manuscript Type

Clinical Research

Abstract Category *

Oncology: Bladder and UTUC

Author's Information

Number of Authors (including submitting/presenting author) *

No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.

Co-author 1

Cheng-Yu Chen ym960813@gmail.com Chi-Mei Medical Center Division of Urology, Department of Surgery Tainan Taiwan *

Co-author 2

Co-author 3

Co-author 4

Co-author 5

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Co-author 16

Co-author 17

Co-author 18

Co-author 19

Co-author 20

Abstract Content

Introduction

We compared the utilization of maintenance and induction intravesical chemotherapy (IVC) in the treatment of non-muscle invasive bladder cancer (NMIBC) in the aspect of recurrence, progression, and survival.

Materials and Methods

A total 45 maintenance IVC patients and 50 induction IVC patients were enrolled. They received whether Epirubicin or Mitomycin-c in protocol. We analyzed the recurrence- free survival(RFS), overall survival(OS) and complication in the follow-up of 4 years.

Results

In comparison of maintenance and induction IVC, there was no significant difference in recurrence-free survival (p=0.82) and overall survival (p=0.45). No statically significant difference of complication (p=0.67) after IVC was found between the two groups.

Conclusions

Current guidelines remain controversial type and regimen for IVC of NMIBC patients, though maintenance therapy is a standard way of BCG instillation. In our study, there was no significant between maintenance and induction therapy in the aspect of RFS, OS and complication.

Keywords

Figure 1

https://storage.unitedwebnetwork.com/files/1237/9c89ad173e44df52d46a0eb278451e11.jpg

Figure 1 Caption

Patient inclusion

Figure 2

https://storage.unitedwebnetwork.com/files/1237/edb62d023f53be10786ee6eb0cfbe1ac.jpg

Figure 2 Caption

Patient characteristics

Figure 3

https://storage.unitedwebnetwork.com/files/1237/8d13733e1200233a2a019cdd5f0b7419.jpg

Figure 3 Caption

primary result

Figure 4

https://storage.unitedwebnetwork.com/files/1237/1cc2edd37b8d4f93b5fb927d07c3e54f.jpg

Figure 4 Caption

adverse effect

Figure 5

Figure 5 Caption

Presentation Order